Total Payments
$11,387
2024 Payments
$1,067
Companies
50
Transactions
922
Medicare Patients
9,444
Medicare Billing
$519,010
Payment Breakdown by Category
Food & Beverage$11,343 (99.6%)
Education$43.54 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,343 | 916 | 99.6% |
| Education | $43.54 | 6 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,085 | 115 | $0 (2024) |
| PFIZER INC. | $989.06 | 114 | $0 (2024) |
| ABBVIE INC. | $916.99 | 77 | $0 (2024) |
| Amgen Inc. | $828.75 | 53 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $627.61 | 40 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $590.44 | 48 | $0 (2024) |
| Abbott Laboratories | $545.95 | 47 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $540.41 | 46 | $0 (2022) |
| Allergan, Inc. | $534.36 | 61 | $0 (2020) |
| Novo Nordisk Inc | $532.74 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,067 | 78 | ABBVIE INC. ($232.14) |
| 2023 | $1,300 | 101 | AbbVie Inc. ($225.58) |
| 2022 | $1,118 | 75 | ABBVIE INC. ($274.41) |
| 2021 | $1,637 | 116 | GlaxoSmithKline, LLC. ($186.35) |
| 2020 | $1,320 | 102 | Kowa Pharmaceuticals America, Inc. ($166.01) |
| 2019 | $1,232 | 103 | Allergan Inc. ($131.55) |
| 2018 | $1,708 | 157 | PFIZER INC. ($249.31) |
| 2017 | $2,005 | 190 | PFIZER INC. ($234.79) |
All Payment Transactions
922 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $9.30 | General |
| Category: Diabetes Care | ||||||
| 12/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Bone Health | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $4.38 | General |
| Category: Diabetes Care | ||||||
| 11/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.27 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Hepatitis B Vaccine | ||||||
| 11/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: Diabetes Care | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: Diabetes Care | ||||||
| 10/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Biological | ||||||
| 09/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Inflammation | ||||||
| 09/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.04 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: VACCINES | ||||||
| 09/15/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Diabetes Care | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: Diabetes Care | ||||||
| 08/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 993 | 2,417 | $244,394 | $109,463 |
| 2022 | 16 | 1,124 | 2,896 | $262,836 | $121,434 |
| 2021 | 34 | 2,738 | 4,615 | $331,307 | $132,580 |
| 2020 | 42 | 4,589 | 7,566 | $484,038 | $155,533 |
Total Patients
9,444
Total Services
17,494
Medicare Billing
$519,010
Procedure Codes
106
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 333 | 592 | $108,748 | $42,095 | 38.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 14 | 1,140 | $37,080 | $20,940 | 56.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 89 | 89 | $21,965 | $10,630 | 48.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 93 | 93 | $12,585 | $6,679 | 53.1% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 48 | 48 | $11,328 | $6,167 | 54.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 128 | $15,869 | $5,721 | 36.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $10,778 | $5,614 | 52.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 48 | $12,276 | $5,174 | 42.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 97 | 97 | $4,944 | $2,700 | 54.6% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 48 | 48 | $2,400 | $1,781 | 74.2% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 16 | 16 | $1,600 | $593.76 | 37.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $1,009 | $556.60 | 55.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 46 | $2,300 | $430.16 | 18.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 32 | 32 | $1,512 | $380.28 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 353 | 636 | $113,208 | $46,368 | 41.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 14 | 1,440 | $42,480 | $24,369 | 57.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 95 | 95 | $21,755 | $11,543 | 53.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 33 | 33 | $17,457 | $9,177 | 52.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 132 | 168 | $19,824 | $7,888 | 39.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 107 | 107 | $12,305 | $7,334 | 59.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 46 | 49 | $11,760 | $5,008 | 42.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 111 | 111 | $5,550 | $2,917 | 52.6% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 58 | 58 | $5,800 | $2,021 | 34.9% |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | Office | 2022 | 44 | 44 | $3,327 | $1,547 | 46.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 42 | 42 | $2,100 | $1,111 | 52.9% |
About Dr. Roberto Saez, MD
Dr. Roberto Saez, MD is a Internal Medicine healthcare provider based in Bentonville, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811925910.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roberto Saez, MD has received a total of $11,387 in payments from pharmaceutical and medical device companies, with $1,067 received in 2024. These payments were reported across 922 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($11,343).
As a Medicare-enrolled provider, Saez has provided services to 9,444 Medicare beneficiaries, totaling 17,494 services with total Medicare billing of $519,010. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Bentonville, AR
- Active Since 06/28/2006
- Last Updated 09/24/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1811925910
Products in Payments
- UBRELVY (Drug) $566.28
- Livalo (Drug) $540.41
- FARXIGA (Drug) $513.78
- XARELTO (Drug) $501.09
- FREESTYLE LIBRE (Device) $441.55
- ELIQUIS (Drug) $433.77
- TRELEGY ELLIPTA (Drug) $429.62
- QULIPTA (Drug) $359.17
- JARDIANCE (Drug) $333.16
- CHANTIX (Drug) $272.89
- EVENITY (Biological) $267.16
- SHINGRIX (Biological) $264.18
- Otezla (Drug) $255.28
- Biktarvy (Drug) $224.45
- Ozempic (Drug) $212.97
- NURTEC ODT (Drug) $209.15
- VRAYLAR (Drug) $183.95
- XIFAXAN (Drug) $167.71
- LYRICA (Drug) $145.84
- LINZESS (Drug) $136.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bentonville
Daniel Young, Md, MD
Internal Medicine — Payments: $41,853
Internal Medicine $41,853
Ms. Brenda Rude, Md, MD
Internal Medicine — Payments: $10,040
Internal Medicine $10,040
Rupali Paradkar, Md, MD
Internal Medicine — Payments: $9,607
Internal Medicine $9,607
Dr. Maria Baldasare, M.d, M.D
Internal Medicine — Payments: $8,287
Internal Medicine $8,287
Dr. Shalini Bichala, Mbbs, MBBS
Internal Medicine — Payments: $4,309
Internal Medicine $4,309
Dr. James Byrum, Md, MD
Internal Medicine — Payments: $4,054
Internal Medicine $4,054